Chagas Cardiomyopathy

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER INC.
Citação
Fernandes, F.; Moreira, C. H. V.; Barbosa-Ferreira, J. M.; Sabino, E. C.. Chagas Cardiomyopathy. In: . THE HEART IN RHEUMATIC, AUTOIMMUNE AND INFLAMMATORY DISEASES: PATHOPHYSIOLOGY, CLINICAL ASPECTS AND THERAPEUTIC APPROACHES: ELSEVIER INC., 2017. p.553-574.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Chagas disease is one of the most important parasitic infections in South America. Trypanosoma cruzi is the protozoan implicated in the development of ChD. Persistent low-grade parasitemia, accompanied by an unbalanced immune response, appears to be the main pathogenic mechanism underlying myocardial damage, microvascular dysfunction, and neuronal cell loss. Chronic phase can be divided into four clinical forms: indeterminate, cardiac, digestive, and mixed (cardiac and digestive impairment in the same patient). Although chronic Chagas' cardiomyopathy is an important cause of heart failure in Latin America and is a unique clinical entity with unique therapeutic characteristics, these patients have not been included in large-scale studies assessing drugs to treat heart failure. Thus the real efficacy and tolerability of these drugs in these patients have not been scientifically established and their use has been extrapolated empirically from the results obtained for heart failure due to other etiologies. © 2017 Elsevier Inc. All rights reserved.
Palavras-chave
Angiotensin-converting-enzyme, Antitrypanosomal therapy, Beta-blockers, Blood transfusion, Cardiac transplantation, Cellular transplantation, Chagas disease, Congenital, Diuretics, Echocardiography, Electrocardiography, Myocardial fibrosis, Nuclear medicine, Oral transmission, Organ transplantation, Trypanosoma cruzi, Trypomastigotes
Referências
  1. Hotez, P.J., Bottazzi, M.E., Franco-Paredes, C., Ault, S.K., Periago, M.R., The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination (2008) PLoS Negl Trop Dis, 2 (9)
  2. Chagas, C., Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen. n. sp., ajente etiolojico de nova entidade morbida do homem (1909) Mem Inst Oswaldo Cruz, 1 (2)
  3. Bestetti, R.B., Martins, C.A., Cardinalli-Neto, A., Justice where justice is due: a posthumous nobel prize to Carlos chagas (1879-1934), the discoverer of American trypanosomiasis (chagas' disease) (2009) Int J Cardiol, 134 (1), pp. 9-16
  4. Lagoeiro, B.G., (2012) Carlos Chagas. Um homem, uma doença, uma historia, , UFF
  5. Lewinsohn, R., Carlos Chagas (1879-1934): the discovery of Trypanosoma cruzi and of American trypanosomiasis (foot-notes to the history of Chagas's disease) (1979) Trans R Soc Trop Med Hyg, 73 (5), pp. 513-523
  6. Epidemiologia e Serviços de Saude (2004) Revista do Sistema único de Saúde, p. 237
  7. Guhl, F., Jaramillo, C., Vallejo, G.A., Yockteng, R., Cárdenas-Arroyo, F., Fornaciari, G., Isolation of Trypanosoma cruzi DNA in 4,000-year-old mummified human tissue from northern Chile (1999) Am J Phys Anthropol, 108 (4), pp. 401-407
  8. Aufderheide, A.C., Salo, W., Madden, M., Streitz, J., Buikstra, J., Guhl, F., A 9,000-year record of Chagas' disease (2004) Proc Natl Acad Sci USA, 101 (7), pp. 2034-2039
  9. Coura, J.R., Dias, J.C., Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery (2009) Mem Inst Oswaldo Cruz, 104, pp. 31-40
  10. Marin-Neto, J.A., Rassi, A., Morillo, C.A., Avezum, A., Connolly, S.J., Sosa-Estani, S., Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) (2008) Am Heart J, 156 (1), pp. 37-43
  11. Rocha, M.O., Nunes, M.C., Ribeiro, A.L., Morbidity and prognostic factors in chronic chagasic cardiopathy (2009) Mem Inst Oswaldo Cruz, 104, pp. 159-166
  12. Talvani, A., Rocha, M.O., Ribeiro, A.L., Correa-Oliveira, R., Teixeira, M.M., Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease (2004) J Infect Dis, 189 (2), pp. 214-220
  13. Rassi, A., Little, W.C., Xavier, S.S., Rassi, S.G., Rassi, A.G., Rassi, G.G., Development and validation of a risk score for predicting death in Chagas' heart disease (2006) N Engl J Med, 355 (8), pp. 799-808
  14. Braga, J.C., Reis, F., Aras, R., Costa, N.D., Bastos, C., Silva, R., Clinical and therapeutics aspects of heart failure due to Chagas disease (2006) Arq Bras Cardiol, 86 (4), pp. 297-302
  15. Leon, J.S., Wang, K., Engman, D.M., Captopril ameliorates myocarditis in acute experimental Chagas disease (2003) Circulation, 107 (17), pp. 2264-2269
  16. de Paula Costa, G., Silva, R.R., Pedrosa, M.C., Pinho, V., de Lima, W.G., Teixeira, M.M., Enalapril prevents cardiac immune-mediated damage and exerts antiTrypanosoma cruzi activity during acute phase of experimental Chagas disease (2010) Parasite Immunol, 32 (3), pp. 202-208
  17. MaC, M., Wang, Y., Heringer-Walther, S., Wessel, N., Walther, T., Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides (2009) Congest Heart Fail, 15 (2), pp. 75-81
  18. Quiros, F.R., Morillo, C.A., Casas, J.P., Cubillos, L.A., Silva, F.A., CHARITY: chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973] (2006) Trials, 7, p. 21
  19. Doval, H.C., Nul, D.R., Grancelli, H.O., Perrone, S.V., Bortman, G.R., Curiel, R., Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) (1994) Lancet, 344 (8921), pp. 493-498
  20. Dias, J.C., Prata, A., Correia, D., Problems and perspectives for Chagas disease control: in search of a realistic analysis (2008) Rev Soc Bras Med Trop, 41 (2), pp. 193-196
  21. Garguichevich, J.J., Ramos, J.L., Gambarte, A., Gentile, A., Hauad, S., Scapin, O., Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA) (1995) Am Heart J, 130 (3), pp. 494-500
  22. Carlier, Y., Sosa-Estani, S., Luquetti, A.O., Buekens, P., Congenital Chagas disease: an update (2015) Mem Inst Oswaldo Cruz, 110 (3), pp. 363-368
  23. Carmo, A.A., Rocha, M.O., Silva, J.L., Ianni, B.M., Fernandes, F., Sabino, E.C., Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease (2015) Int J Cardiol, 189, pp. 182-184
  24. Soares, M.B., Lima, R.S., Rocha, L.L., Takyia, C.M., Pontes-de-Carvalho, L., de Carvalho, A.C., Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice (2004) Am J Pathol, 164 (2), pp. 441-447
  25. Carvalho, K.A., Guarita-Souza, L.C., Hansen, P., Rebelatto, C.L., Senegaglia, A.C., Miyague, N., Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats (2006) Transpl Proc, 38 (5), pp. 1596-1602
  26. Guarita-Souza, L.C., Carvalho, K.A., Woitowicz, V., Rebelatto, C., Senegaglia, A., Hansen, P., Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease (2006) Circulation, 114, pp. I120-I124
  27. Szlachcic, J., Massie, B.M., Kramer, B.L., Topic, N., Tubau, J., Correlates and prognostic implication of exercise capacity in chronic congestive heart failure (1985) Am J Cardiol, 55 (8), pp. 1037-1042
  28. Ribeiro Dos Santos, R., Rassi, S., Feitosa, G., Grecco, O.T., Rassi, A., da Cunha, A.B., Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial (2012) Circulation, 125 (20), pp. 2454-2461
  29. Benvenuti, L.A., Roggério, A., Sambiase, N.V., Fiorelli, A., Higuchi, M., Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas' disease in heart transplantation: a case report and review of the literature (2005) Cardiovasc Pathol, 14 (5), pp. 265-268
  30. Bacal, F., Silva, C.P., Bocchi, E.A., Pires, P.V., Moreira, L.F., Issa, V.S., Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols (2005) Am J Transpl, 5 (8), pp. 2017-2021
  31. Dumonteil, E., Bottazzi, M.E., Zhan, B., Heffernan, M.J., Jones, K., Valenzuela, J.G., Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects (2012) Expert Rev Vaccines, 11 (9), pp. 1043-1055
  32. Schmunis, G.A., Epidemiology of Chagas disease in nonendemic countries: the role of international migration (2007) Mem Inst Oswaldo Cruz, 102, pp. 75-85
  33. Nery-Guimarães, F.S.N., Calusell, D.T., Mello, A.L., Rapone, T., Snell, T., Rodrigues, N., Um surto epidêmico de doença de Chagas de provável transmissão digestiva ocorrido em Teutônia (1968) Hospital, , [Report No.: Contract No]
  34. Machado, F.S., Tyler, K.M., Brant, F., Esper, L., Teixeira, M.M., Tanowitz, H.B., Pathogenesis of Chagas disease: time to move on (2012) Front Biosci (Elite Ed), 4, pp. 1743-1758
  35. Hotez, P.J., Dumonteil, E., Heffernan, M.J., Bottazzi, M.E., Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas (2013) Adv Exp Med Biol, 764, pp. 1-12
  36. Molina, I., Gómez i Prat, J., Salvador, F., Treviño, B., Sulleiro, E., Serre, N., Randomized trial of posaconazole and benznidazole for chronic Chagas' disease (2014) N Engl J Med, 370 (20), pp. 1899-1908
  37. Ministério, S., Brazilian consensus on chagas disease (2005)
  38. (2011) Neglected tropical diseases [Internet], , http://www.cdc.gov/%20globalhealth/ntd/, Available from:
  39. Buhaya, M.H., Galvan, S., Maldonado, R.A., Incidence of Trypanosoma cruzi infection in triatomines collected at Indio Mountains Research Station (2015) Acta Trop, 150, pp. 97-99
  40. Bern, C., Kjos, S., Yabsley, M.J., Montgomery, S.P., Trypanosoma cruzi and chagas' disease in the United States (2011) Clin Microbiol Rev, 24 (4), pp. 655-681
  41. Oster, A.M., Brooks, J.T., Stryker, J.E., Kachur, R.E., Mead, P., Pesik, N.T., Interim guidelines for prevention of sexual transmission of Zika Virus - United States, 2016 (2016) MMWR Morb Mortal Wkly Rep, 65 (5), pp. 120-121
  42. Blood donor screening for chagas disease-United States, 2006-2007 (2007) MMWR Morb Mortal Wkly Rep, 56 (7), pp. 141-143
  43. Piron, M., Vergés, M., Muñoz, J., Casamitjana, N., Sanz, S., Maymó, R.M., Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain) (2008) Transfusion, 48 (9), pp. 1862-1868
  44. Jansen, A.M., Moriearty, P.L., Castro, B.G., Deane, M.P., Trypanosoma cruzi in the opossum Didelphis marsupialis: an indirect fluorescent antibody test for the diagnosis and follow-up of natural and experimental infections (1985) Trans R Soc Trop Med Hyg, 79 (4), pp. 474-477
  45. Martins-Melo, F.R., Ramos, A.N., Alencar, C.H., Heukelbach, J., Mortality related to chagas disease and HIV/AIDS coinfection in Brazil (2012) J Trop Med, 2012, p. 534649
  46. Andrade, C.M., Câmara, A.C., Nunes, D.F., Guedes, P.M., Pereira, W.O., Chiari, E., Chagas disease: morbidity profile in an endemic area of Northeastern Brazil (2015) Rev Soc Bras Med Trop, 48 (6), pp. 706-715
  47. Andrade, J.P., Marin-Neto, J.A., Paola, A.A., Vilas-Boas, F., Oliveira, G.M., Bacal, F., I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy (2011) Arq Bras Cardiol, 97 (2), pp. 1-48
  48. Maguire, J.H., Treatment of chagas' disease - time is running out (2015) N Engl J Med, 373 (14), pp. 1369-1370
  49. Rassi, A., Marcondes de Rezende, J., American trypanosomiasis (Chagas disease) (2012) Infect Dis Clin North Am, 26 (2), pp. 275-291
  50. Gorla, D.N.F., Geographic distribution of Triatominae vectors in America (2010) American trypanosomiasis (Chagas disease) one hundred years of research, pp. 209-231. , Elsevier
  51. Muñoz-Saravia, S.G., Haberland, A., Wallukat, G., Schimke, I., Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine (2012) Heart Fail Rev, 17 (1), pp. 45-64
  52. Dorn, P.L., Perniciaro, L., Yabsley, M.J., Roellig, D.M., Balsamo, G., Diaz, J., Autochthonous transmission of Trypanosoma cruzi, Louisiana (2007) Emerg Infect Dis, 13 (4), pp. 605-607
  53. Coura, J.R., The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - a comprehensive review (2015) Mem Inst Oswaldo Cruz, 110 (3), pp. 277-282
  54. Gomes, Y.M., Lorena, V.M., Luquetti, A.O., Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? (2009) Mem Inst Oswaldo Cruz, 104, pp. 115-121
  55. Alarcón de Noya, B., Díaz-Bello, Z., Colmenares, C., Ruiz-Guevara, R., Mauriello, L., Zavala-Jaspe, R., Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela (2010) J Infect Dis, 201 (9), pp. 1308-1315
  56. Coura, J.R., Borges-Pereira, J., Chagas disease: 100 years after its discovery. A systemic review (2010) Acta Trop, 115 (1-2), pp. 5-13
  57. Pedro.W., Revision of triatomines (Hemiptera, Reduvidae) and their significance as vectors of Chagas' disease (1979) Bulletin of the American Museum of natural history, , H. Lent (Ed.)
  58. Oliveira, I., Torrico, F., Muñoz, J., Gascon, J., Congenital transmission of Chagas disease: a clinical approach (2010) Expert Rev Anti Infect Ther, 8 (8), pp. 945-956
  59. Coura, J.R., Epidemiologic determinants of Chagas' disease in Brazil: the infection, the disease and its morbidity/mortality (1988) Mem Inst Oswaldo Cruz, 83, pp. 392-402
  60. Vilas-Boas, F., Ribeiro-dos-Santos, R., Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease (2006) Arq Bras Cardiol, 87 (2)
  61. Macedo, A.M., Pena, S.D., Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of chagas disease (1998) Parasitol Today, 14 (3), pp. 119-124
  62. Zingales, B., Andrade, S.G., Briones, M.R., Campbell, D.A., Chiari, E., Fernandes, O., A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI (2009) Mem Inst Oswaldo Cruz, 104 (7), pp. 1051-1054
  63. Rassi, A., Marin-Neto, J.A., Chagas disease (2010) Lancet, 375 (9723), pp. 1388-1402
  64. Lopes, A., Tratado de clínica médica (2009) Doença de Chagas, pp. 4123-4134. , Editora Roca Ed., Sao Paulo, A.R.A.J. Rassi, S.G. Rassi (Eds.)
  65. Brener, Z., Lifecycle of Trypanosoma cruzi (1971) Rev Inst Med Trop Sao Paulo, 13 (3), pp. 171-178
  66. Nóbrega, A.A., Garcia, M.H., Tatto, E., Obara, M.T., Costa, E., Sobel, J., Oral transmission of Chagas disease by consumption of açaí palm fruit (2009) Brazil Emerg Infect Dis, 15 (4), pp. 653-655
  67. Howard, E.J., Xiong, X., Carlier, Y., Sosa-Estani, S., Buekens, P., Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis (2014) BJOG, 121 (1), pp. 22-33
  68. Kaplinski, M., Jois, M., Galdos-Cardenas, G., Rendell, V.R., Shah, V., Do, R.Q., Sustained domestic vector exposure is associated with increased chagas cardiomyopathy risk but decreased parasitemia and congenital transmission risk among young women in Bolivia (2015) Clin Infect Dis, 61 (6), pp. 918-926
  69. Bern, C., Verastegui, M., Gilman, R.H., Lafuente, C., Galdos-Cardenas, G., Calderon, M., Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia (2009) Clin Infect Dis, 49 (11), pp. 1667-1674
  70. Pérez-Molina, J.A., Perez, A.M., Norman, F.F., Monge-Maillo, B., López-Vélez, R., Old and new challenges in Chagas disease (2015) Lancet Infect Dis, 15 (11), pp. 1347-1356
  71. Bern, C., Montgomery, S.P., Herwaldt, B.L., Rassi, A., Marin-Neto, J.A., Dantas, R.O., Evaluation and treatment of Chagas disease in the United States: a systematic review (2007) JAMA, 298 (18), pp. 2171-2181
  72. Ribeiro, A.L., Nunes, M.P., Teixeira, M.M., Rocha, M.O., Diagnosis and management of Chagas disease and cardiomyopathy (2012) Nat Rev Cardiol, 9 (10), pp. 576-589
  73. Ramirez, J.D., Guhl, F., Umezawa, E.S., Morillo, C.A., Rosas, F., Marin-Neto, J.A., Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods (2009) J Clin Microbiol, 47 (12), pp. 3945-3951
  74. Otani, M.M., Vinelli, E., Kirchhoff, L.V., del Pozo, A., Sands, A., Vercauteren, G., WHO comparative evaluation of serologic assays for Chagas disease (2009) Transfusion, 49 (6), pp. 1076-1082
  75. Control of Chagas disease (2002) World Health Organ Tech Rep Ser, 905, pp. i-vi. , 1-109, back cover
  76. Oliveira-Filho, J., Viana, L.C., Vieira-de-Melo, R.M., Faiçal, F., Torreão, J.A., Villar, F.A., Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort (2005) Stroke, 36 (9), pp. 2015-2017
  77. Chang, C.D., Cheng, K.Y., Jiang, L.X., Salbilla, V.A., Haller, A.S., Yem, A.W., Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening (2006) Transfusion, 46 (10), pp. 1737-1744
  78. Umezawa, E.S., Bastos, S.F., Camargo, M.E., Yamauchi, L.M., Santos, M.R., Gonzalez, A., Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America (1999) J Clin Microbiol, 37 (5), pp. 1554-1560
  79. Caballero, Z.C., Sousa, O.E., Marques, W.P., Saez-Alquezar, A., Umezawa, E.S., Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp (2007) Clin Vaccin Immunol, 14 (8), pp. 1045-1049
  80. Umezawa, E.S., Nascimento, M.S., Kesper, N., Coura, J.R., Borges-Pereira, J., Junqueira, A.C., Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease (1996) J Clin Microbiol, 34 (9), pp. 2143-2147
  81. Saez-Alquezar, A., Sabino, E.C., Salles, N., Chamone, D.F., Hulstaert, F., Pottel, H., Serological confirmation of Chagas' disease by a recombinant and peptide antigen line immunoassay: INNO-LIA chagas (2000) J Clin Microbiol, 38 (2), pp. 851-854
  82. Shah, D.O., Chang, C.D., Cheng, K.Y., Salbilla, V.A., Adya, N., Marchlewicz, B.A., Comparison of the analytic sensitivities of a recombinant immunoblot assay and the radioimmune precipitation assay for the detection of antibodies to Trypanosoma cruzi in patients with Chagas disease (2010) Diagn Microbiol Infect Dis, 67 (4), pp. 402-405
  83. Remesar, M.C., Gamba, C., Colaianni, I.F., Puppo, M., Sartor, P.A., Murphy, E.L., Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina (2009) Transfusion, 49 (11), pp. 2352-2358
  84. Salles, N.A., Sabino, E.C., Cliquet, M.G., Eluf-Neto, J., Mayer, A., Almeida-Neto, C., Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors (1996) Transfusion, 36 (11-12), pp. 969-973
  85. Sabino, E.C., Lee, T.H., Montalvo, L., Nguyen, M.L., Leiby, D.A., Carrick, D.M., Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time (2013) Transfusion, 53 (6), pp. 1257-1265
  86. Dias, J.C., Dias, E., Martins-Filho, O.A., Vitelli-Avelar, D., Correia, D., Lages, E., Further evidence of spontaneous cure in human Chagas disease (2008) Rev Soc Bras Med Trop, 41 (5), pp. 505-506
  87. Mady, C., Cardoso, R.H., Barretto, A.C., da Luz, P.L., Bellotti, G., Pileggi, F., Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy (1994) Circulation, 90 (6), pp. 3098-3102
  88. Francolino, S.S., Antunes, A.F., Talice, R., Rosa, R., Selanikio, J., de Rezende, J.M., New evidence of spontaneous cure in human Chagas' disease (2003) Rev Soc Bras Med Trop, 36 (1), pp. 103-107
  89. Zeledon, R., Dias, J.C., Brilla-Salazar, A., de Rezende, J.M., Vargas, L.G., Urbina, A., Does a spontaneous cure for Chagas' disease exist? (1988) Rev Soc Bras Med Trop, 21 (1), pp. 15-20
  90. de Andrade, A.L., Zicker, F., de Oliveira, R.M., Almeida Silva, S., Luquetti, A., Travassos, L.R., Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection (1996) Lancet, 348 (9039), pp. 1407-1413
  91. Viotti, R., Vigliano, C., Lococo, B., Bertocchi, G., Petti, M., Alvarez, M.G., Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial (2006) Ann Intern Med, 144 (10), pp. 724-734
  92. Schijman, A.G., Bisio, M., Orellana, L., Sued, M., Duffy, T., Mejia Jaramillo, A.M., International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients (2011) PLoS Negl Trop Dis, 5 (1)
  93. Sabino, E.C., Ribeiro, A.L., Lee, T.H., Oliveira, C.L., Carneiro-Proietti, A.B., Antunes, A.P., Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity (2015) Eur J Heart Fail, 17 (4), pp. 416-423
  94. Morillo, C.A., Marin-Neto, J.A., Avezum, A., Sosa-Estani, S., Rassi, A., Rosas, F., Randomized trial of benznidazole for chronic chagas' cardiomyopathy (2015) N Engl J Med, 373 (14), pp. 1295-1306
  95. Britto, C., Cardoso, M.A., Vanni, C.M., Hasslocher-Moreno, A., Xavier, S.S., Oelemann, W., Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation (1995) Parasitology, 110 (PT 3), pp. 241-247
  96. Moreira, O.C., Ramirez, J.D., Velazquez, E., Melo, M.F., Lima-Ferreira, C., Guhl, F., Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial (2013) Acta Trop, 125 (1), pp. 23-31
  97. Bern, C., Chagas' disease (2015) N Engl J Med, 373 (19), p. 1882
  98. Corbucci, H.A., Haber, D.M., Bestetti, R.B., Cordeiro, J.A., Fioroni, M.L., QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance (2006) Cardiovasc Pathol, 15 (1), pp. 18-23
  99. Britto, C.C., Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations (2009) Mem Inst Oswaldo Cruz, 104, pp. 122-135
  100. Caradonna, K.L., Burleigh, B.A., Mechanisms of host cell invasion by Trypanosoma cruzi (2011) Adv Parasitol, 76, pp. 33-61
  101. Johndrow, C., Nelson, R., Tanowitz, H., Weiss, L.M., Nagajyothi, F., Trypanosoma cruzi infection results in an increase in intracellular cholesterol (2014) Microbes Infect, 16 (4), pp. 337-344
  102. Andrade, D.V., Gollob, K.J., Dutra, W.O., Acute chagas disease: new global challenges for an old neglected disease (2014) PLoS Negl Trop Dis, 8 (7)
  103. Dos Santos Virgilio, F., Pontes, C., Dominguez, M.R., Ersching, J., Rodrigues, M.M., Vasconcelos, J.R., CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development? (2014) Mediators Inflamm, 2014, p. 243786
  104. Tanowitz, H.B., Jelicks, L.A., Machado, F.S., Esper, L., Qi, X., Desruisseaux, M.S., Adipose tissue, diabetes and Chagas disease (2011) Adv Parasitol, 76, pp. 235-250
  105. Lewis, M.D., Fortes Francisco, A., Taylor, M.C., Burrell-Saward, H., McLatchie, A.P., Miles, M.A., Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection (2014) Cell Microbiol, 16 (9), pp. 1285-1300
  106. Cunha-Neto, E., Teixeira, P.C., Nogueira, L.G., Kalil, J., Autoimmunity (2011) Adv Parasitol, 76, pp. 129-152
  107. Nussinovitch, U., Shoenfeld, Y., The clinical and diagnostic significance of antimyosin autoantibodies in cardiac disease (2013) Clin Rev Allergy Immunol, 44 (1), pp. 98-108
  108. Nussinovitch, U., Shoenfeld, Y., The clinical significance of antiβ-1 adrenergic receptor autoantibodies in cardiac disease (2013) Clin Rev Allergy Immunol, 44 (1), pp. 75-83
  109. Barbosa, M.P.C.A., Rocha, M.O., Ribeiro, A.L., Ventricular arrhythmias in Chagas disease (2015) Rev Soc Bras Med Trop, 48 (1), pp. 4-10
  110. Nussinovitch, U., Shoenfeld, Y., The diagnostic and clinical significance of antimuscarinic receptor autoantibodies (2012) Clin Rev Allergy Immunol, 42 (3), pp. 298-308
  111. Marin-Neto, J.A., Cunha-Neto, E., Maciel, B.C., Simões, M.V., Pathogenesis of chronic Chagas heart disease (2007) Circulation, 115, pp. 1109-1123
  112. (2009) Definicion de la OMS de caso de infección por el VIH a efectos de vigilancia y revisión de la estadifi cació n clnica y de la clasificació n inmunoló gica de la enfermedad relacionada con el VIH en adultos y niños
  113. Jackson, Y., Gétaz, L., Wolff, H., Holst, M., Mauris, A., Tardin, A., Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland (2010) PLoS Negl Trop Dis, 4 (2)
  114. Sartori, A.M., Ibrahim, K.Y., Nunes Westphalen, E.V., Braz, L.M., Oliveira, O.C., Gakiya, E., Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS (2007) Ann Trop Med Parasitol, 101 (1), pp. 31-50
  115. Sartori, A.M., Lopes, M.H., Caramelli, B., Duarte, M.I., Pinto, P.L., Neto, V., Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS (1995) Clin Infect Dis, 21 (5), pp. 1297-1299
  116. Casadei, D., Chagas' disease and solid organ transplantation (2010) Transpl Proc, 42 (9), pp. 3354-3359
  117. Altclas, J.D., Barcan, L., Nagel, C., Lattes, R., Riarte, A., Organ transplantation and Chagas disease (2008) JAMA, 299 (10), p. 1134. , author reply -5
  118. Bocchi, E.A., Fiorelli, A., The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology (2001) Ann Thorac Surg, 71 (6), pp. 1833-1838
  119. Diez, M., Favaloro, L., Bertolotti, A., Burgos, J.M., Vigliano, C., Lastra, M.P., Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation (2007) Am J Transpl, 7 (6), pp. 1633-1640
  120. Sarabanda, A.V., Sosa, E., Simões, M.V., Figueiredo, G.L., Pintya, A.O., Marin-Neto, J.A., Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms (2005) Int J Cardiol, 102 (1), pp. 9-19
  121. Ianni, B.M., Arteaga, E., Frimm, C.C., Pereira Barretto, A.C., Mady, C., Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form (2001) Arq Bras Cardiol, 77 (1), pp. 59-62
  122. Sabino, E.C., Ribeiro, A.L., Salemi, V.M., Di Lorenzo Oliveira, C., Antunes, A.P., Menezes, M.M., Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors (2013) Circulation, 127 (10), pp. 1105-1115
  123. Köberle, F., Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis (1968) Adv Parasitol, 6, pp. 63-116
  124. Bellotti, G., Bocchi, E.A., de Moraes, A.V., Higuchi, M.L., Barbero-Marcial, M., Sosa, E., In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease (1996) Am Heart J, 131 (2), pp. 301-307
  125. Barbosa-Ferreira, J.M.M.C., Ianni, B.M., Lopes, H.F., Ramires, F.J., Salemi, V.M., Grupi, C.J., Dysregulation of autonomic nervous system in Chagas' heart disease is associated with altered adipocytokines levels (2015) PLoS One, 10 (7)
  126. Silva, C.E.F.L., Peixoto, L.B., Monaco, C.G., Gil, M.A., Ortiz, J., Evaluation of segmentar contractility in Chagas' disease by using the integral of the myocardial velocity gradiente(myocardial strain) obtained through tissue Doppler echocardiography (2005) Arq Bras Cardiol, 84, pp. 285-291
  127. Ribeiro, A.L., Moraes, R.S., Ribeiro, J.P., Ferlin, E.L., Torres, R.M., Oliveira, E., Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease (2001) Am Heart J, 141 (2), pp. 260-265
  128. Rocha, A.L., Lombardi, F., da Costa Rocha, M.O., Barros, M.V., Val Barros, V., Reis, A.M., Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients (2006) Ann Noninvasive Electrocardiol, 11 (1), pp. 3-11
  129. Barros, M.V., Rocha, M.O., Ribeiro, A.L., Machado, F.S., Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas' disease and normal echocardiogram (2001) Echocardiography, 18 (2), pp. 131-136
  130. Camargo, M.E., da Silva, G.R., de Castilho, E.A., Silveira, A.C., Serological survey of the prevalence of Chagas' infection in Brazil, 1975/1980 (1984) Rev Inst Med Trop Sao Paulo, 26 (4), pp. 192-204
  131. Mady, C.P.-B.A., Ianni, B.M., Lopes, E.A., Pileggi, F., Right ventricular endomyocardial biopsy in indeterminate form of Chagas' disease (1984) Angiology, 35, pp. 755-759
  132. Pereira Barretto, A.C., Mady, C., Arteaga-Fernandez, E., Stolf, N., Lopes, E.A., Higuchi, M.L., Right ventricular endomyocardial biopsy in chronic Chagas' disease (1986) Am Heart J, 111 (2), pp. 307-312
  133. Ortiz, J.P.-B.A., Matsumoto, A., Alteração contrátil segmentar na forma indeterminada da doença de Chagas. Estudo ecocardiográfico (1987) Arq Bras Cardiol, 49, pp. 217-220
  134. Peix, A.G.R., Sánchez, J., Cabrera, L.O., Padrón, K., Vedia, O., Myocardial perfusion imaging and cardiac involvement in the indeterminate phase of Chagas disease (2013) Arq Bras Cardiol, 100 (2), pp. 114-117
  135. Marin-Neto, J.A., Marzullo, P., Marcassa, C., Gallo Júnior, L., Maciel, B.C., Bellina, C.R., Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy (1992) Am J Cardiol, 69 (8), pp. 780-784
  136. Simões, M.V., Pintya, A.O., Bromberg-Marin, G., Sarabanda, A.V., Antloga, C.M., Pazin-Filho, A., Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy (2000) Am J Cardiol, 86 (9), pp. 975-981
  137. Hiss, F.C., Lascala, T.F., Maciel, B.C., Marin-Neto, J.A., Simões, M.V., Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy (2009) JACC Cardiovasc Imaging, 2 (2), pp. 164-172
  138. Rochitte, C.E., Oliveira, P.F., Andrade, J.M., Ianni, B.M., Parga, J.R., Avila, L.F., Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity (2005) J Am Coll Cardiol, 46 (8), pp. 1553-1558
  139. Rochitte, C.E., Nacif, M.S., de Oliveira Júnior, A.C., Siqueira-Batista, R., Marchiori, E., Uellendahl, M., Cardiac magnetic resonance in Chagas' disease (2007) Artif Organs, 31 (4), pp. 259-267
  140. Mady, C., Fernandes, F., Arteaga, E., Ramires, F.J., Buck, P., Salemi, V.M., Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies (2008) Arq Bras Cardiol, 91 (1), pp. 46-54
  141. Silveira, A.C., Silva, G.R., Prata, A., Seroprevalence survey of human Chagas' infection (1975-1980) (2011) Rev Soc Bras Med Trop, 44, pp. 33-39
  142. MaC, M., Heringer-Walther, S., Wessel, N., Moreira Ventura, T., Wang, Y., Schultheiss, H.P., Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation (2008) Cardiology, 110 (4), pp. 217-225
  143. Lima-Costa, M.F., Cesar, C.C., Peixoto, S.V., Ribeiro, A.L., Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging (2010) Am J Epidemiol, 172 (2), pp. 190-196
  144. Ribeiro, A.L., Teixeira, M.M., Reis, A.M., Talvani, A., Perez, A.A., Barros, M.V., Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach (2006) Int J Cardiol, 109 (1), pp. 34-40
  145. Fernandes, F., Dantas, S., Ianni, B.M., Ramires, F.J., Buck, P., Salemi, V.M., Leptin levels in different forms of Chagas' disease (2007) Braz J Med Biol Res, 40 (12), pp. 1631-1636
  146. Bonney, K.M., Taylor, J.M., Daniels, M.D., Epting, C.L., Engman, D.M., Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity (2011) PLoS One, 6 (1)
  147. Cunha-Neto, E., Bilate, A.M., Hyland, K.V., Fonseca, S.G., Kalil, J., Engman, D.M., Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry (2006) Autoimmunity, 39 (1), pp. 41-54
  148. Cunha-Neto, E., Duranti, M., Gruber, A., Zingales, B., De Messias, I., Stolf, N., Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen (1995) Proc Natl Acad Sci USA, 92 (8), pp. 3541-3545
  149. Cunha-Neto, E., Coelho, V., Guilherme, L., Fiorelli, A., Stolf, N., Kalil, J., Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient (1996) J Clin Invest, 98 (8), pp. 1709-1712
  150. Reis, M.M., Higuchi, M., Benvenuti, L.A., Aiello, V.D., Gutierrez, P.S., Bellotti, G., An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens (1997) Clin Immunol Immunopathol, 83 (2), pp. 165-172
  151. Cunha-Neto, E., Rizzo, L.V., Albuquerque, F., Abel, L., Guilherme, L., Bocchi, E., Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy (1998) Braz J Med Biol Res, 31 (1), pp. 133-137
  152. Report of a WHO Expert Committee (1991) World Health Organ Tech Rep Ser, 811, pp. 1-95
  153. Abel, L.C., Rizzo, L.V., Ianni, B., Albuquerque, F., Bacal, F., Carrara, D., Chronic Chagas' disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection (2001) J Autoimmun, 17 (1), pp. 99-107
  154. Gomes, J.A., Bahia-Oliveira, L.M., Rocha, M.O., Martins-Filho, O.A., Gazzinelli, G., Correa-Oliveira, R., Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response (2003) Infect Immun, 71 (3), pp. 1185-1193